Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment (Q38396192)

2 September 2017

1 reference

title

Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment (English)

1 reference

2 September 2017

main subject

prostatic hypertrophy

1 reference

David Mobley

1 reference

2 September 2017

Allison Feibus

series ordinal

1 reference

2 September 2017

Neil Baum

series ordinal

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 2015

1 reference

2 September 2017

published in

Postgraduate Medicine

1 reference

2 September 2017

volume

127

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

301-307

1 reference

Evaluation and treatment of lower urinary tract symptoms in older men.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

PSA screening among elderly men with limited life expectancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Mirabegron: a safety review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Effects of Acute Treatment With Tamsulosin Versus Alfuzosin on Ejaculatory Function in Normal Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

Bipolar electrosurgery for benign prostatic hyperplasia: transurethral electrovaporization and resection of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1018799

10.1080/00325481.2015.1018799

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference